Last edition
News about "DTAB has recommended that the proposed provisions "
Drug Technical Advisory Board suggests recommendations under clinical trial to DCGI
DTAB has recommended that the proposed provisions for grant of licence to manufacture and stock of new drug which is under clinical trial is considered appropriate for drugs/vaccines being developed for emergency/life-saving/COVID-19 and similar such conditions of public health importance
DTAB Has Recommended That The Proposed Provisions | 14/02/2022 | By Darshana | 409
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members